“It sounds like science fiction, but we’re very excited by the potential of this yeast-based vaccine production system.” — ...
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results